These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19353471)

  • 1. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
    Pawlita M; Gissmann L
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination.
    Freed GL; Derkay CS
    Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1799-803. PubMed ID: 16884786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
    Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
    JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of mucosal human papillomavirus infection and associated diseases.
    Trottier H; Burchell AN
    Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Juvenile laryngeal papillomatosis--immunisation with the polyvalent vaccine gardasil].
    Förster G; Boltze C; Seidel J; Pawlita M; Müller A
    Laryngorhinootologie; 2008 Nov; 87(11):796-9. PubMed ID: 18759217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
    Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
    Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
    Kimberlin DW
    Antiviral Res; 2004 Sep; 63(3):141-51. PubMed ID: 15451182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus.
    Hawkes M; Campisi P; Zafar R; Punthakee X; Dupuis A; Forte V; Ford-Jones EL
    Pediatr Infect Dis J; 2008 Feb; 27(2):149-54. PubMed ID: 18174855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case for immunization of human papillomavirus (HPV) 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma.
    Shah KV
    J Infect Dis; 2014 May; 209(9):1307-9. PubMed ID: 24265442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
    Novakovic D; Cheng AT; Cope DH; Brotherton JM
    Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
    Lacey CJ; Lowndes CM; Shah KV
    Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children.
    Donne AJ; Clarke R
    Int J STD AIDS; 2010 Jun; 21(6):381-5. PubMed ID: 20606216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent respiratory papillomatosis: update 2008.
    Gallagher TQ; Derkay CS
    Curr Opin Otolaryngol Head Neck Surg; 2008 Dec; 16(6):536-42. PubMed ID: 19005325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
    Sullivan C; Curtis S; Mouzakes J
    Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
    Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
    Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
    Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
    JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
    Yiu Y; Fayson S; Smith H; Matrka L
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.